TENX
TENAX THERAPEUTICS, INC.
Recent 8-K filings for TENX
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 12:00 UTC earnings item 2.02item 9.01
Tenax Q1 net loss $15.7M; cash $118.8M; Phase 3 topline data expected Q3 2026
source · TENX on sec.gov